Reach out

Please select an option

Please enter a valid email address

Please complete this field

400 characters limit

Please complete this field

400 characters limit

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We help UCL innovators scale globally

We support founders across the Physical and Life Sciences with capital and scale-up expertise.

Why Us

UCLTF provides investment to support the research commercialisation journey.

Learn more

At a Glance

UCLTF has been investing in commercialisation opportunities from UCL since 2016.

34

Portfolio Companies

19

Licensing Projects

34

Proof-of-concept Investments

4

Nasdaq IPOs

News & Stories

Latest news and views from the team, companies and UCL ecosystem.
VIEW ALL NEWS

News

AstronauTx appoints Jane Rhodes as Chief Executive Officer

Investments

Gaussion raises $12m to revolutionize battery charging

Investments

EpilepsyGTx announces a $10M fundraise to complete the CTA-enabling nonclinical package for lead program EPY201

News

New immunotherapy from UCL researchers to treat bone cancer shows promise

Investments

Oriole Networks raises a £10m seed round to build AI ‘super-brains’

Investments

UCL Spinout Stanhope AI raises £2.3 million

News

UCL Spinout Echopoint Medical Ltd Secures £4.2 Million in Series A Funding, Advancing FDA Approval Process for iKOr System

Investments

Oriole Networks raises a further $22m led by Plural to reduce energy consumption of AI data centres

News

Cancer Research UK and NovalGen collaborate to advance T-cell engager into the clinic

Highlights

Video highlights from the Fund and our backed companies.

Prof. Amit Nathwani, CEO, Novalgen From Academia to biotech Entrepreneur

Tony Kenyon, CSO & Co-founder Intrinsic From Research to Industry

Prof. Amit Nathwani, CEO, Novalgen From Academia to biotech Entrepreneur

Tony Kenyon, CSO & Co-founder Intrinsic From Research to Industry

VIEW ALL VIDEOS

Let’s Talk

UCLTF offers investment throughout the commercialisation journey. We fund proof-of-concept and development projects, and support founding teams with company formation.

Learn more

Reach out

Related Content

We help UCL innovators scale globally

Why Us

At a Glance

34

19

34

4

News & Stories

AstronauTx appoints Jane Rhodes as Chief Executive Officer

Gaussion raises $12m to revolutionize battery charging

EpilepsyGTx announces a $10M fundraise to complete the CTA-enabling nonclinical package for lead program EPY201

New immunotherapy from UCL researchers to treat bone cancer shows promise

Oriole Networks raises a £10m seed round to build AI ‘super-brains’

UCL Spinout Stanhope AI raises £2.3 million

UCL Spinout Echopoint Medical Ltd Secures £4.2 Million in Series A Funding, Advancing FDA Approval Process for iKOr System

Oriole Networks raises a further $22m led by Plural to reduce energy consumption of AI data centres

Cancer Research UK and NovalGen collaborate to advance T-cell engager into the clinic

Highlights

Prof. Amit Nathwani, CEO, Novalgen From Academia to biotech Entrepreneur

Tony Kenyon, CSO & Co-founder Intrinsic From Research to Industry

Prof. Amit Nathwani, CEO, Novalgen From Academia to biotech Entrepreneur

Tony Kenyon, CSO & Co-founder Intrinsic From Research to Industry

Let’s Talk